0
Aerie Pharmaceuticals Inc Banner Image

Aerie Pharmaceuticals Inc

  • Ticker AERI
    Exchange NASDAQ More
  • Industry Drug Manufacturers - Major More
  • Sector Healthcare More
Aerie Pharmaceuticals Inc Logo Image
  • 201-500 Employees
  • Based in Durham, North Carolina
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. Its product candidates include Rhopressa, which is a once-daily eye drop that reduces intraocular pressure (IOP) in patients with glaucoma or ocular hypertension and is in PhaseMore III registration trials; and Roclatan, a once-daily eye drop to reduce IOP that has completed Phase IIb clinical trial in patients with open-angle glaucoma and ocular hypertension.
Aerie Pharmaceuticals Inc

Most Recent Annual Report

Aerie Pharmaceuticals Inc MOST RECENT 2019 Annual Report and Form 10K

Older/Archived Annual Reports